A prodrug nanodevice co-delivering docetaxel and ROR1 siRNA for enhanced triple negative breast cancer therapy
Lixuan Yin, Zirang Fu, Mengmeng Wang, Bo Liu, Xujie Sun, Kaiyue Liu, Xiaolong Feng, Zongyan He, Yutong Wang, Jiazhen Hou, Xinyue Shao, Ning Yang, T. Zhang, Yiran Liu, Zheng-Wei Huang, Qi Yin, Yuanchao Xie, Yaping Li, Tianqun Lang
Topics & Concepts
NanodeviceTriple-negative breast cancerDocetaxelProdrugMaterials scienceBreast cancerCancer researchNanomedicinePharmacologyMedicineOncologyCancerNanotechnologyInternal medicineNanoparticleRNA Interference and Gene DeliveryNanoplatforms for cancer theranosticsAdvanced biosensing and bioanalysis techniques